Frequent expression of PD-L1 on circulating breast cancer cells-Reference-Cited by-同舟云学术

Frequent expression of PD-L1 on circulating breast cancer cells

Published:2015-06-09 Issue:9 Volume:9 Page:1773-1782
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:

Author:

Mazel Martine,Jacot William,Pantel Klaus,Bartkowiak Kai,Topart Delphine,Cayrefourcq Laure,Rossille Delphine,Maudelonde Thierry,Fest Thierry,Alix-Panabières Catherine

Funder

University Medical Centre of Rennes

ANR-Roche SAS grant (TF)

FEDER

Region Languedoc-Roussillon

Kastner Foundation

European Research Council

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.molonc.2015.05.009/fullpdf

Reference28 articles.

1. Circulating tumor cells: liquid biopsy of cancer;Alix-Panabieres;Clin. Chem.,2013

2. Challenges in circulating tumour cell research;Alix-Panabieres;Nat. Rev. Cancer,2014

3. Circulating tumor cells and circulating tumor DNA;Alix-Panabieres;Annu. Rev. Med.,2012

4. Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials;Bidard;Cancer Metastasis Rev.,2013

5. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer;Brahmer;N. Engl. J. Med.,2012

Cited by 320 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating tumor cells: from new biological insights to clinical practice;Signal Transduction and Targeted Therapy;2024-09-02

2. Liquid biopsy: paving a new avenue for cancer research;Cell Adhesion & Migration;2024-09

3. Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the ALICE and ICON trials;Molecular Oncology;2024-07-08

4. Interactions between platelets and the cancer immune microenvironment;Critical Reviews in Oncology/Hematology;2024-07

5. Prognostic significance of programmed cell death ligand 1 blood markers in non-small cell lung cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis;Frontiers in Immunology;2024-06-10